The purpose of this study is to determine the importance of uptake drug transporters in the drug disposition of warfarin. We predict that the elimination of warfarin will be decreased when co-dosed with an inhibitor of uptake drug transporters.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Enrollment
10
warfarin 7.5mg po x 1; rifampin 600mg IV x 1
warfarin 7.5mg po x 1
UCSF Medical Center
San Francisco, California, United States
S- and R- Enantiomers of Warfarin (S-warfarin and R-warfarin) Area Under the Plasma Concentration-time Curve (AUC) From 0 to 12 Hours.
Uptake effects on warfarin pharmacokinetics during time period of hepatic organic anion-transporting polypeptide (OATP) inhibition by rifampin. Blood collection 1, 2, 4, 6, 8, and 12 hours after warfarin dosing.
Time frame: 0-12 hours after warfarin dosing
Area Under the Plasma Concentration-time Curve From Time Zero to Infinity of S-warfarin and R-warfarin
Analysis of all concentration-time data. Blood collection 1, 2, 4, 6, 8, 12, 24, 48, 72, 96, and 120 hours after warfarin dosing.
Time frame: 0-120 hours after warfarin dosing
Maximum Plasma Concentration (Cmax) of S-warfarin and R-warfarin
Blood collection 1, 2, 4, 6, 8, 12, 24, 48, 72, 96, and 120 hours after warfarin dosing.
Time frame: 0-120 hours after warfarin dosing
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.